Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.4244
+0.0658 (18.35%)
At close: Oct 21, 2026, 4:00 PM EDT
0.427013
+0.0026 (0.62%)
Pre-market: Oct 22, 2026, 9:00 AM EDT
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 228 employees as of December 31, 2025. The number of employees decreased by 51 or 18.28% compared to the previous year. That makes Karyopharm Therapeutics the 25,873rd largest employer in the world and 3,287th in the United States.
Employees
228
Change (1Y)
-51
Growth (1Y)
-18.28%
Revenue / Employee
$643,075
Profits / Employee
-$985,702
Market Cap
9.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 228 | -51 | -18.28% |
| Dec 31, 2024 | 279 | -46 | -14.15% |
| Dec 31, 2023 | 325 | -60 | -15.58% |
| Dec 31, 2022 | 385 | -57 | -12.90% |
| Dec 31, 2021 | 442 | 10 | 2.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Palatin Technologies | 25 |
| BioLineRx | 24 |
| Lisata Therapeutics | 21 |
| Theriva Biologics | 16 |
| Lantern Pharma | 16 |
| BioVie | 13 |
| Ensysce Biosciences | 10 |
| MetaVia | 8 |
KPTI News
- 20 days ago - Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - Karyopharm, guarantors enter into forbearance agreement - TheFly
- 7 weeks ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 7 weeks ago - Karyopharm submits sNDA to FDA for XPOVIO - TheFly
- 7 weeks ago - Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis - PRNewsWire
- 2 months ago - Karyopharm reports Q2 EPS ($2.32) vs. ($4.32) last year - TheFly
- 2 months ago - Karyopharm Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Karyopharm Therapeutics Earnings release: Q2 2026 - Filings